+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 2
Age: 18Years - 75Years
All Genders
ID07239336

Evaluating the Effects of DONQ52 Compared to Placebo on Intestinal Healing and Symptoms in Adults with Active Celiac Disease Following a Gluten-Free Diet

Led by Chugai Pharmaceutical · Updated on 2026-08-14

92

Participants Needed

74

Research Sites

26 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are evaluating the effects of DONQ52 on small intestinal damage and celiac-related symptoms in people with active celiac disease who are trying to maintain a gluten-free diet. This Phase II study compares the effects of DONQ52 with a placebo in participants who have ongoing duodenal mucosal damage and persistent symptoms despite following a gluten-free diet. The goal is to see how DONQ52 influences intestinal healing and symptom reduction related to gluten exposure. Participants receive either DONQ52 or a placebo through subcutaneous injections, combined with oral capsules simulating inadvertent gluten exposure SIGE. The study lasts 27 weeks, during which participants maintain their gluten-free diet and follow the protocol for taking the study treatments. Two upper gastrointestinal endoscopies with duodenal biopsies are performed to assess intestinal damage. Throughout the study, participants undergo regular assessments including symptom diaries for gastrointestinal symptoms, blood tests to monitor drug levels and immune responses, and safety evaluations for adverse events. The primary measure is the change in the villous height to crypt depth ratio over 27 weeks, indicating intestinal healing. Additional measurements track symptom changes and immune reactions up to 47 weeks, ensuring long-term monitoring of treatment effects and safety.

CONDITIONS

Brief Title

Study of DONQ52 in Active Celiac Disease

Research Team

C

Clinical trials information

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here